Skip to content

Abliva

Delivering mitochondrial health

  • English
    • English
    • Svenska
  • Abliva
    • This is Abliva
      • Strategy
      • Orphan Drugs
    • Board
    • Team
    • Partners
    • Relevant publications
  • Mitochondrial Disease
    • Primary mitochondrial disease
      • MELAS-MIDD and KSS-CPEO
      • Leigh Syndrome
      • LHON
    • Patients
    • Expanded access policy
  • Research & Development
    • Portfolio
      • KL1333
      • NV354
      • Early programs
    • Clinical trials
      • The FALCON Study
    • Partnering
      • BD Contact
  • Investors
    • Financial reports
      • Annual reports
      • Interim reports
      • Other financial information
    • Financial Calendar
    • Share and owner information
    • Equity research
    • Corporate governance
      • Corporate Governance Reports
      • Annual General Meeting (AGM)
      • Articles of Association
      • Board of Directors
      • Committees
      • Auditor
      • Group management
      • Incentive programs
    • Current general meeting
    • General meetings archive
    • IR contact
  • News
    • Press releases
    • Newsletters
    • Events and Presentations
      • World Mitochondrial Disease Week 2023
    • Company Calendar
    • News subscription
    • Press photos
    • Media contact
    • Privacy policy
  • Contact

Current general meeting

Annual General Meeting 2024

Annual General Meeting in Abliva AB will be held on Thursday, May 23, 2024, at 1 p.m. CEST at Medicon Village, Scheeletorget 1, in Lund, Sweden.

The Nomination Committee for the 2024 AGM comprises:

  • Ingrid Teigland Akay (ordförande) – for Hadean Ventures
  • Sam Williams – for IP Group plc
  • Ryan El Housseini – for OPF (Oslo Pensionsfond)
    Investor relations

    General meetings archive

    Annual General Meeting 2024 Annual General Meeting in Abliva AB will be held on Thursday, May 23, 2024, at 1 p.m. CEST at Medicon Village, Scheeletorget 1, in Lund, Sweden. The Nomination Committee for the 2024 AGM comprises: Ingrid Teigland Akay (ordförande) – for Hadean Ventures Sam Williams – for IP Group plc Ryan El Housseini – for OPF (Oslo Pensionsfond) ...

    Investor relations

    Share and owner information

    Abliva AB is listed on Nasdaq Stockholm and trades under the ticker ABLI. The share capital is SEK 52,814,958.25 divided between 1,056,299,165 shares of only one class. All shares have a quotient value of […]

    Investor relations

    Corporate governance

    Corporate governance covers the structures and processes by which the company is governed. The objective of good corporate governance is to increase confidence in listed companies, increase their value for shareholders, and safeguard financial strength.

    Popular shortcuts

    Research & Development
    Investors
    Primary mitochondrial disease
    Interim reports

    Receive updates straight to your inbox

    Choose the categories that you are interested in, and check preferred language.

    1. Startpage
    2. Investors
    3. Current general meeting

    This is Abliva

    • Strategy
    • Board
    • Team
    • Partners and advisers
    • Relevant publications

    Research & Development

    • Research & Development
    • KL1333
    • NV354
    • Early programs
    • Partnering
    • BD Contact

    Investors

    • Investors
    • Annual reports
    • Interim reports
    • Other financial information
    • Financial Calendar
    • Share and owner information
    • Equity research
    • Corporate governance
    • Current general meeting
    • General meetings archive
    • IR contact

    News

    • Press releases
    • Newsletters
    • Events and Presentations
    • Capital Markets Day 2020
    • Mitochondria Day 2020
    • News subscription
    • Press photos
    • Media contact
    • Privacy policy

    Contact

    Abliva AB (publ)
    Medicon Village
    223 81 Lund, Sweden

    Phone
    +46 (0)46-275 62 20

    Generel questions
    info@abliva.com

    © Copyright 2020 – Abliva AB. All rights reserved. | We use cookies to improve our services | Cookie policy | Privacy policy

    Cookies
    We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
    Settings Accept all
    Cookies
    Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
    • Necessary
      These cookies are not optional. They are needed for the website to function.
    • Statistics
      In order for us to improve the website's functionality and structure, based on how the website is used.
    • Experience
      In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
    • Marketing
      By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
    Save Accept all